You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
個股熱度排行 | 7月26日港股盤前

根據uSMART輿情監測數據,從25日晚間到26日港股盤前時間段,市場關注指數最高的5只股票是阿裏巴巴-SW、復星醫藥、海吉亞醫療、葉氏化工集團、時代天使。

7月26日—港股關注排行TOP5

輿情變化榜單

阿裏巴巴-SW

個股K線圖

關注度第一爲阿裏巴巴-SW,該股上個交易日收盤下跌2.45%,報於99.60港元。近5個交易日累計下跌4.14%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

阿裏巴巴申請香港轉爲主要上市、料年底完成 有望成港股通投資範圍

阿裏巴巴集團尋求於港交所主要上市 完成後將於紐約交易所及港交所雙重主要上市

復星醫藥

個股K線圖

關注度第二爲復星醫藥,該股上個交易日收盤上漲1.62%,報於31.35港元。近5個交易日累計持平。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

復星醫藥與真實生物達成戰略合作 聯合開發及獨家商業化阿茲夫定

俄羅斯要削減北溪輸氣量,歐洲天然氣暴漲;日本發現首例猴痘,多國防控升級;首款國產新冠口服藥獲批!復星醫藥官宣合作

海吉亞醫療

個股K線圖

關注度第三爲海吉亞醫療,該股上個交易日收盤下跌4.28%,報於45.90港元。近5個交易日累計下跌9.29%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

海吉亞醫療斥648萬人民幣增持賀州廣濟醫院1%

海吉亞醫療擬斥648.05萬元收購賀州廣濟醫院1%股權

葉氏化工集團

個股K線圖

關注度第四爲葉氏化工集團,該股上個交易日收盤上漲6.79%,報於4.56港元。近5個交易日累計上漲15.74%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

葉氏化工集團附屬擬22.95億元出售所持謙信化工發展68%股權

葉氏化工集團擬22.95億元出售謙信化工發展68%股權 明日復牌

時代天使

個股K線圖

關注度第五爲時代天使,該股上個交易日收盤下跌2.45%,報於151.20港元。近5個交易日累計上漲5.96%。在消息面和社交媒體方面,輿情以看空爲主。較被市場關注的消息有:

時代天使預期上半年淨利潤同比減少27.3%至30.9%

時代天使發盈警 預期中期淨利潤同比減少27.3%至30.9%

此外,監測期內有1只股票的輿情出現大扭轉,意味着在消息面上出現了可能影響公司股價趨勢的事件或者轉折。

7月26日—港股輿情轉折預警

輿情變化榜單

阿裏巴巴-SW

個股K線圖

阿裏巴巴-SW輿情扭轉指數達99,目前輿情方向爲利好,表明公司出現了被投資者視作較大利好的消息。

其中較被市場關注的消息有:

阿裏巴巴申請香港轉爲主要上市、料年底完成 有望成港股通投資範圍

阿裏巴巴集團尋求於港交所主要上市 完成後將於紐約交易所及港交所雙重主要上市

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account